Melatonin

Overview

Melatonin is a hormone produced mainly by the pineal gland deep in the brain. Its central job is not to knock you out but to tell your body what time it is. Moderate evidence Levels rise in the evening as light fades, peak in the middle of the night, and fall toward morning, making melatonin the body's chemical announcement that biological night has begun. Because of this role, it is best understood as a circadian signal, a message about timing, rather than a classic sleeping pill.

As a supplement, melatonin is one of the most widely used sleep aids in the world, and its regulatory status varies: it is available over the counter in some countries and is prescription-only in others. The evidence base is reasonably solid for two things in particular, helping people fall asleep a bit faster and easing jet lag, but the size of those effects is modest, and the marketing around melatonin often outruns the data.

This profile is educational and does not recommend taking melatonin or any other product. It summarizes what controlled research suggests, along with the meaningful caveats about effect size and product quality.

How it works

Melatonin's effects flow from the body's master clock, a small region of the hypothalamus called the suprachiasmatic nucleus (SCN). The SCN keeps roughly 24-hour time and is reset each day primarily by light reaching the eyes. When darkness falls, the SCN signals the pineal gland to release melatonin, and that melatonin then acts back on receptors in the SCN and elsewhere to reinforce the message that it is night.

Two receptor subtypes, MT1 and MT2, mediate most of its actions. Broadly, activating them promotes the onset of sleep and helps align the circadian rhythm. This is why timing matters so much with melatonin: taken at the right point relative to your internal clock, a small amount can nudge the whole rhythm earlier or later. Taken at the wrong time, it can be ineffective or even push the clock in an unhelpful direction. This phase-shifting property is the mechanistic reason melatonin is useful for jet lag and certain circadian rhythm disruptions, where the goal is to move the clock rather than simply to sedate.

It is worth emphasizing what melatonin is not. It does not act like alcohol, antihistamines, or prescription hypnotics that broadly depress the nervous system. Its sleep effect is gentler and more indirect, working with the circadian system rather than overriding it. That distinction explains both its relatively favorable short-term tolerability and its comparatively modest effect on any single night's sleep.

What the research shows

The most useful summary of melatonin for ordinary sleep comes from meta-analyses that pool many randomized trials. A frequently cited 2013 meta-analysis in PLoS ONE by Ferracioli-Oda and colleagues found that melatonin modestly reduced the time needed to fall asleep, increased total sleep time, and improved self-rated sleep quality compared with placebo. Earlier analyses, including work summarized by Brzezinski and colleagues in Sleep Medicine Reviews in 2005, similarly found a reduction in sleep onset latency, while being candid that the average effect measured in minutes was small.

The picture is stronger for jet lag. A Cochrane review by Herxheimer and Petrie concluded that melatonin is effective for preventing or reducing jet lag in travelers crossing several time zones, with the benefit most apparent for eastward travel and greater numbers of zones crossed. This aligns neatly with the mechanism: jet lag is fundamentally a clock-alignment problem, exactly the kind of thing a timing signal is suited to address. Melatonin has also been studied in delayed sleep-wake phase disorder and in some populations with disrupted circadian rhythms, again with the theme that its value lies in shifting timing.

A crucial and often overlooked strand of research concerns product quality rather than biology. An analysis by Erland and Saxena published in the Journal of Clinical Sleep Medicine in 2017 examined commercial melatonin supplements and found that the actual melatonin content frequently differed substantially from the labeled amount, with variability from batch to batch and, in some cases, unexpected contaminants. Because melatonin is a hormone and its effects depend on getting a modest, well-timed exposure, this inconsistency is not a trivial concern; it means two products bearing the same label may behave quite differently.

Evidence quality

Melatonin earns a "Moderate" rating because the direction of its effects is well supported by multiple randomized trials and meta-analyses, but the magnitude is unimpressive and the literature has real limitations. For sleep onset in the general population, the average benefit, measured in minutes saved before falling asleep, is small enough that individuals vary widely in whether they notice anything at all. Total sleep time and quality improvements are similarly modest on average.

Several factors keep this from being a "Strong" rating. Study designs are heterogeneous, with different amounts, timing, populations, and outcome measures, which complicates pooling and can inflate apparent effects. Timing is frequently not optimized in trials, even though timing is central to how melatonin works, so some studies may understate what well-timed use could achieve while others may overstate it. Long-term safety data, particularly for continuous use over months to years and in children and adolescents, are thinner than the drug's popularity would suggest. And the product-quality problem described above introduces noise into the entire evidence base, since a "melatonin" study is only as clean as the melatonin used.

The jet lag evidence is the most convincing part of the portfolio and is where the mechanism, the trials, and the practical logic converge most cleanly.

Open questions

Key uncertainties remain. What is the ideal timing relative to an individual's own body clock, and how much would personalizing that timing improve results compared with the fixed evening use studied in most trials? How do very different amounts compare head to head, given evidence that lower exposures can work as well as higher ones for falling asleep while producing fewer next-day effects? What are the long-term consequences, if any, of routinely supplementing a hormone, especially in young people whose endocrine systems are still developing?

There are also open questions about melatonin beyond sleep. It is an antioxidant and has been studied in a range of conditions, and it is sometimes discussed in longevity contexts, but the evidence for benefits outside sleep and circadian alignment is far less developed and should be treated with caution.

For readers, the balanced summary is this: melatonin is a genuine biological timing signal with modest, real effects on falling asleep and a stronger case for jet lag, wrapped in a marketplace where product contents are inconsistent and claims often exceed the science. Understanding it as a clock-setting tool rather than a powerful sedative is the single most useful frame the research supports. Anyone weighing its use, especially for a child, alongside other medications, or over the long term, should discuss it with a qualified healthcare professional.